Fundraising FoxBranch Therapeutics
Houston, US · Founded 2024 · Delaware corporation
Find your way into Branch Therapeutics
Sign up to see every warm intro you have to Branch Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Branch Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Branch Therapeutics develops first-in-class, orally available dual-kinase inhibitors designed to modulate WNT/β-catenin and PI3Kα signaling to target cancer stem cells and treatment resistance in solid tumors. The company pairs its therapies with a precision biomarker strategy aimed at safer, longer-lasting responses to cancer treatment.
Founders & leadership
Branch Therapeutics was founded in 2024 by Curtis Thorne.
Board
SB
Sourav BanerjeeBoard director
Reported raises · per SEC filings
Form D private placements$4M disclosed across 1 round · 2025
▶$4MraisedMay 2025 · 1 investors · PharmaceuticalsRule 506(b)
▶$4MraisedMay 2025 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Sourav BanerjeeDirector
- Curtis ThorneExecutive Officer, Director
- Christopher HulmeDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Branch Therapeutics do?
- Branch Therapeutics develops first-in-class, orally available dual-kinase inhibitors designed to modulate WNT/β-catenin and PI3Kα signaling to target cancer stem cells and treatment resistance in solid tumors. The company pairs its therapies with a precision biomarker strategy aimed at safer, longer-lasting responses to cancer treatment.
- Who founded Branch Therapeutics?
- Branch Therapeutics was founded by Curtis Thorne in 2024.
- How much funding has Branch Therapeutics raised?
- Branch Therapeutics has disclosed $4M raised across 1 round.
- Where is Branch Therapeutics headquartered?
- Branch Therapeutics is headquartered in Houston, US.